Company Overview
American HealthCare Capital is pleased to exclusively introduce a highly profitable medical sales and consulting company for sale in the Midwest. Founded in 2018, the company partners with leading manufacturers and suppliers of regenerative biologics and wound care products, serving as a dedicated outsourced salesforce. It focuses on sales, case coverage, and clinical consulting while suppliers handle all billing and collections.
The company operates with exceptional efficiency and profitability. Its client base includes wound care centers, mobile wound care providers, podiatry practices, and private outpatient clinics. By providing subject-matter expertise, clinical oversight, and staff training—not just pricing—the company has created long-term, sticky client relationships.
The Current Market
The regenerative biologics market is undergoing a major transition, with providers expected to concentrate purchasing on products backed by strong clinical evidence. Beginning in January 2026, new Medicare rules will narrow the range of products that clinics are willing and able to adopt, which is likely to reduce overall sales volumes and pressure many competitors. The company’s asset-light, commission-based model is well positioned to adapt quickly, capture additional demand, and expand its market share as sales consolidate around fewer, clinically validated products.
Financial Overview
The company has experienced rapid growth in recent years, with revenue increasing from $4.2 million in 2023 to $8.3 million in 2024, and over $9.1 million in 2025 through June, putting them on track to exceed $18.2 million by the end of year. EBITDA has doubled annually and is expected to reach over $16 million in 2025. With industry shifts expected in 2026, management anticipates revenue in the $6–$8 million range and EBITDA of approximately $4–$5 million under the new payment environment. Despite these shifts, the company is strategically aligned with manufacturers whose products meet the latest clinical and reimbursement standards, ensuring continuity and positioning it for growth.
Staffing Overview
The company is supported by a lean team of salespeople who are expected to remain with the business following a transition. The owner is committed to assisting with a six- to twelve-month transition post-sale to ensure continuity with clients, suppliers, and staff.
Asking Price
The asking price for this opportunity is $30 million, which does not include cash, receivables, or working capital.
